Enanta Pharmaceuticals
ENTA
#7602
Rank
A$0.56 B
Marketcap
A$19.48
Share price
0.80%
Change (1 day)
109.99%
Change (1 year)

Enanta Pharmaceuticals (ENTA) Fails to deliver data

Key failure to deliver metrics for Enanta Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Enanta Pharmaceuticals (ENTA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Enanta Pharmaceuticals (ENTA) - since 2013

Volume in USD (price x number of shares), data since 2013

Enanta Pharmaceuticals (ENTA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$0.15 M-84.93%
2025A$1.05 M-0.21%
2024A$1.05 M-33.48%
2023A$1.58 M-69.53%
2022A$5.19 M37.3%
2021A$3.78 M22.27%
2020A$3.09 M-14.77%
2019A$3.63 M-54.06%
2018A$7.9 M134.04%
2017A$3.37 M-70.94%
2016A$11.63 M-27.35%
2015A$16 M21.11%
2014A$13.21 M124.82%
2013A$5.87 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$67.61 MA$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$0.27 BA$0.38 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$0.13 BA$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$53.89 MA$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$43.21 MA$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$21.15 MA$68.65 M๐Ÿ‡บ๐Ÿ‡ธ USA